The Medicines and Health products Regulatory Agency (MHRA) has issued a drug recall for Itraconazole 10mg/ml oral solution of Thame Laboratories.
The drug manufacturer, Thame Laboratories, has recalled Itraconazole batches due to an issue with the container closure (child-resistant cap).
The marketing authorisation holder has received a number of complaints regarding the child-resistant caps which were difficult to open, and their investigation has identified an issue with the bottle capping process during the manufacture of the product.
|Batch Number||Expiry Date||Pack Size||First Distributed|
|L465||03/2022||150ml||25 Jan 2021|
|L475||03/2022||150ml||25 Jan 2021|
Community pharmacists have been advised to stop supplying all impacted batches immediately and quarantine remaining stock to return it to the concerned supplier using supplier’s approved process.